Elicio Therapeutics, Inc. Common Stock (ELTX) is a publicly traded Healthcare sector company. As of November 10, 2026, ELTX trades at $1.69 with a market cap of $40.91M and a P/E ratio of -0.75. ELTX moved +2.74% today. Year to date, ELTX is -79.55%; over the trailing twelve months it is -81.44%. Its 52-week range spans $1.25 to $16.00. Analyst consensus is buy with an average price target of $15.50. Rallies surfaces ELTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks ELTX insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $1.69 |
| Market Cap | $40.91M |
| P/E Ratio | -0.75 |
| EPS | $-2.58 |
| Dividend Yield | 0.00% |
| 52-Week High | $16.00 |
| 52-Week Low | $1.25 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-39.57M |
| Gross Margin | 0.00% |
3 analysts cover ELTX: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $15.50.